Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

ClinicalTrials.gov ID: NCT02892422

Public ClinicalTrials.gov record NCT02892422. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Open-label, Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.

Study identification

NCT ID
NCT02892422
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
528 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2016 (Actual)
Primary completion
Oct 10, 2019 (Actual)
Completion
Oct 10, 2019 (Actual)
Last update posted
Oct 26, 2020

2016 – 2019

United States locations

U.S. sites
32
U.S. states
12
U.S. cities
29
Facility City State ZIP Site status
US1018 Bellflower California — —
US1062 Costa Mesa California 92626 —
US1463 Culver City California — —
US1399 Escondido California 91945 —
US1104 Garden Grove California 92845 —
US1114 National City California 91950 —
US1459 Oceanside California — —
US1368 Orange California 92868 —
US1391 San Bernardino California 92408-3332 —
US1392 Torrance California 90502-4432 —
US1318 Lauderhill Florida 33319 —
US1130 Miami Florida 33122 —
US1129 North Miami Florida 33161-5834 —
US1402 Oakland Park Florida 33334-4400 —
US1403 Atlanta Georgia 30328 —
US1009 Atlanta Georgia 30331 —
US1046 Chicago Illinois 60640 —
US1423 Hoffman Estates Illinois 60169-1067 —
US1398 Shreveport Louisiana 71101-4603 —
US1404 Shreveport Louisiana 71104-2136 —
US1086 Flowood Mississippi 39232 —
US1444 Las Vegas Nevada 89102-1943 —
US1426 Berlin New Jersey 08009 —
US1244 Fresh Meadows New York 11432 —
US1394 New York New York 10032 —
US1416 New York New York 10035-6000 —
US1171 Rochester New York 14618 —
US1190 Staten Island New York 10312-6501 —
US1390 Charlotte North Carolina 28204-3110 —
US1124 Norristown Pennsylvania 19403 —
US1451 Austin Texas 78754-5122 —
US1065 Dallas Texas 75243 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02892422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02892422 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →